The Role of Intestinal Inflammation in the Pathophysiology of IBS

肠道炎症在 IBS 病理生理学中的作用

基本信息

  • 批准号:
    7480910
  • 负责人:
  • 金额:
    $ 15.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-25 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This career development application has two components: I. A mentored research project, and II. Educational/training activities. Epidemiological studies have implicated intestinal inflammation and chronic activation of the immune system in the etiology of IBS for some patients. Recent research in animal models suggests that these factors can be involved in the pathophysiological mechanisms responsible for intestinal dysmotility and visceral hypersensitivity. However, the role of intestinal inflammation and mucosal immune activation has not been adequately and systematically investigated in patients with IBS. In the proposed research project we will compare sub-clinical mucosal inflammation between patients with diarrhea predominant IBS (D-IBS) and control. We will specifically look at pro- and anti-inflammatory cytokines and inflammatory-associated neuropeptides. Analyses will be performed by Real-time PCR and ELISA techniques to verify results. In our second aim we will investigate whether alterations in inflammatory markers are associated with alterations with relevant intestinal physiology including colonic pain thresholds, phasic motility, and smooth muscle tone. We will study 33 IBS patients with D-IBS and 33 healthy controls. Intestinal physiological data will be collected on the same study population of an NIH supported study on the heterogeneity of IBS (NIDDK Grant DK 31369, Whitehead PI) on which Dr. Whitehead is collaborating with Dr. Ringel. The educational/training components of this proposal have been developed with the advice of Dr. Ringel's mentors: Dr. Balfour Sartor is a world renowned expert and researcher in intestinal inflammation and Dr. William Whitehead is a world renowned expert and researcher in functional Gl disorders. We propose formal coursework as well as laboratory training aiming to expand and increase Dr. Ringel's knowledge and skills in theories and research methodologies in these areas. The overall goal is to establish Dr. Ringel as an independently-funded translational researcher. Thus, the methodologies, results and protocols that will be developed during the award will be used to design mechanistic intervention studies and as preliminary data for submission of future (NIH) grants.
描述(由申请人提供): 该职业发展申请有两个组成部分:I. 指导研究项目,II. 指导研究项目。教育/培训活动。流行病学研究表明,肠道炎症和免疫系统的慢性激活是某些患者 IBS 的病因。最近的动物模型研究表明,这些因素可能参与导致肠道运动障碍和内脏过敏的病理生理机制。然而,肠道炎症和粘膜免疫激活的作用尚未在 IBS 患者中得到充分、系统的研究。在拟议的研究项目中,我们将比较腹泻为主的 IBS (D-IBS) 患者和对照患者之间的亚临床粘膜炎症。我们将特别关注促炎和抗炎细胞因子以及炎症相关神经肽。将通过实时 PCR 和 ELISA 技术进行分析以验证结果。在我们的第二个目标中,我们将研究炎症标志物的改变是否与相关肠道生理学的改变相关,包括结肠疼痛阈值、相性运动和平滑肌张力。我们将研究 33 名患有 D-IBS 的 IBS 患者和 33 名健康对照者。将在 NIH 支持的 IBS 异质性研究(NIDDK Grant DK 31369,Whitehead PI)的同一研究人群中收集肠道生理数据,Whitehead 博士与 Ringel 博士合作开展该研究。该提案的教育/培训部分是根据 Ringel 博士导师的建议制定的:Balfour Sartor 博士是肠道炎症领域的世界知名专家和研究员,William Whitehead 博士是功能性胃肠道疾病领域的世界知名专家和研究员。我们提出正式的课程作业以及实验室培训,旨在扩展和提高林格尔博士在这些领域的理论和研究方法方面的知识和技能。总体目标是将林格尔博士打造为一名独立资助的转化研究员。因此,获奖期间将开发的方法、结果和方案将用于设计机械干预研究,并作为提交未来(NIH)拨款的初步数据。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YEHUDA RINGEL其他文献

YEHUDA RINGEL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YEHUDA RINGEL', 18)}}的其他基金

Fecal Microflora in Irritable Bowel Syndrome: Characterization & Significance
肠易激综合症的粪便微生物群落:特征
  • 批准号:
    8072701
  • 财政年份:
    2010
  • 资助金额:
    $ 15.72万
  • 项目类别:
Fecal Microflora in Irritable Bowel Syndrome (IBS): Characterization and Signific
肠易激综合征 (IBS) 中的粪便微生物群落:特征和意义
  • 批准号:
    7896186
  • 财政年份:
    2010
  • 资助金额:
    $ 15.72万
  • 项目类别:
CLINICAL TRIAL: PROBIOTIC BACTERIA IN PATIENTS WITH IBS, FUNCTIONAL DIARRHEA, OR
临床试验:益生菌治疗肠易激综合症、功能性腹泻或
  • 批准号:
    7716794
  • 财政年份:
    2008
  • 资助金额:
    $ 15.72万
  • 项目类别:
YOGURT DRINK CONTAINING BIFIDOBACTERIUM LACTIS (BB12) FUNCTIONAL GASTROINTESTINL
含有乳双歧杆菌 (BB12) 功能性胃肠测试的酸奶饮料
  • 批准号:
    7716904
  • 财政年份:
    2008
  • 资助金额:
    $ 15.72万
  • 项目类别:
ASSOCIATION BETWEEN INTESTINAL MICROFLORA AND MUCOSAL INFLAMMATION IN IBS
IBS 肠道菌群与粘膜炎症之间的关联
  • 批准号:
    7625661
  • 财政年份:
    2006
  • 资助金额:
    $ 15.72万
  • 项目类别:
The Role of Intestinal Inflammation in the Pathophysiology of IBS
肠道炎症在 IBS 病理生理学中的作用
  • 批准号:
    7135224
  • 财政年份:
    2006
  • 资助金额:
    $ 15.72万
  • 项目类别:
The Role of Intestinal Inflammation in the Pathophysiology of IBS
肠道炎症在 IBS 病理生理学中的作用
  • 批准号:
    7920791
  • 财政年份:
    2006
  • 资助金额:
    $ 15.72万
  • 项目类别:
PROBIOTIC BACTERIA IN PATIENTS WITH IBS, FUNCTIONAL DIARRHEA, OR BLOATING
肠易激综合症、功能性腹泻或腹胀患者中的益生菌
  • 批准号:
    7625572
  • 财政年份:
    2006
  • 资助金额:
    $ 15.72万
  • 项目类别:
The Role of Intestinal Inflammation in the Pathophysiology of IBS
肠道炎症在 IBS 病理生理学中的作用
  • 批准号:
    7681542
  • 财政年份:
    2006
  • 资助金额:
    $ 15.72万
  • 项目类别:
ESOMEPRAZOLE IN PATIENTS WITH DIARRHEA PREDOMINANT IBS OR FUNCTIONAL DIARRHEA
埃索美拉唑治疗腹泻为主的肠易激综合征或功能性腹泻患者
  • 批准号:
    7377494
  • 财政年份:
    2005
  • 资助金额:
    $ 15.72万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 15.72万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 15.72万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.72万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 15.72万
  • 项目类别:
    Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
  • 批准号:
    2889694
  • 财政年份:
    2023
  • 资助金额:
    $ 15.72万
  • 项目类别:
    Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 15.72万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 15.72万
  • 项目类别:
    Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 15.72万
  • 项目类别:
    Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 15.72万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 15.72万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了